1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Patient Monitoring Device Market Trends
  5. > Europe Continuous Glucose Monitoring Systems Market - Opportunities and Forecasts, 2014 - 2021

Continuous glucose monitoring system (CGMS) is a device that provides with the real-time glucose monitoring in diabetes patients. This technology helps diabetes patients to track their glucose levels round-the-clock. CGMS devices monitor glucose levels at an interval of every 5 minutes. CGMS devices are used along with blood glucose meters to provide supplementary information to facilitate better glucose monitoring and treatment. This technology can be used in diabetes type 1 as well as diabetes type 2 patients. Continuous glucose monitoring assist in stabilizing elevated A1C levels, thereby, reducing the risk of developing long-term diabetic complications. The adoption of CGMS technology is expected to increase, owing to its application in artificial/bionic pancreas.The Europe CGMS market is estimated to garner $351.7 million by 2021, registering a CAGR of 38.0% during the forecast period. This market is expected to witness significant growth from 2015 to 2021, owing to numerous advantages of CGMS such as minimal invasiveness and real-time blood glucose monitoring. In addition, increasing incidence of diabetes cases in Europe, increasing per capita healthcare expenditure, and growing purchasing power on account of high disposable income of individuals have fueled the market growth. Furthermore, ability of CGMS to provide detailed analysis of blood glucose levels and higher precision as compared to traditional blood glucose monitoring has supplemented the market growth. However, high costs associated with CGMS, lack of adequate reimbursement policies, and limited awareness about CGMS among patients are the major factors hampering the growth of the market.The report segments the Europe CGMS market on the basis of country and components. Based on country, the market is segmented into the U.K., France, Germany, Norway, Sweden, Denmark, Finland and Other Europe. Presently, the Germany leads the Europe CGMS market, owing to its large diabetes patient pool and high healthcare expenditure. The components of the CGMS comprise sensors, transmitters & receivers, and integrated insulin pumps. The sensors segment dominates the market, as the sensor loses its sensitivity after using if for about 5 to 7 days, which requires frequent requirement.Europe CGMS market has presence of numerous manufacturers that are adopting partnership and collaboration as their strategy to commercialize CGMS. For instance, Senseonics and Rubin Medical have adopted the collaboration strategy to commercialize their CGMS products in Denmark and Sweden. The companies profiled in the report include Medtronic Inc., Dexcom, Inc., Abbott Diabetic care, Senseonics Incorporated, Insulet Corporation, Echo therapeutics, Glysens Inc. and Animas Corporation,

KEY BENEFITS
FOR STAKEHOLDERS:This report provides an in-depth analysis of the current and emerging market trends and dynamics in the Europe CGMS market.The European CGMS market is analyzed based on countries such as the U.K., France, Germany, Norway, Sweden, Denmark, Finland, and Other Europe.An in-depth analysis of key strategies adopted by key manufacturers helps in understanding competitive scenario.This report provides an exhaustive analysis of the factors that drive and restrict the growth of the Europe CGMS market.The reimbursement scenario of CGMS devices has been provided in this report.EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET KEY SEGMENTS:BY COUNTRYU.K.FranceGermanyNorwaySwedenDenmarkFinlandOther EuropeBY COMPONENTSSensorsTransmitters & receiversIntegrated insulin pumps

Table Of Contents

Europe Continuous Glucose Monitoring Systems Market - Opportunities and Forecasts, 2014 - 2021
CHAPTER 1 INTRODUCTION1.1 Market definition and scope1.2 Research methodology1.2.1 Secondary research1.2.2 Primary Research1.2.3 Analyst Tools and ModelsCHAPTER 2 EXECUTIVE SUMMARYCHAPTER 3 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)3.1 Overview3.1.1 Market size and forecastCHAPTER 4 U.K. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)4.1 Key market trends4.2 Key growth factors and opportunities4.3 Market size and forecast4.4 Reimbursement scenarioCHAPTER 5 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)5.1 Key market trends5.2 Key growth factors and opportunities5.3 Market size and forecast5.4 Reimbursement scenarioCHAPTER 6 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)6.1 Key market trends6.2 Key growth factors and opportunities6.3 Market size and forecast6.4 Reimbursement scenarioCHAPTER 7 NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)7.1 Key market trends7.2 Key growth factors and opportunities7.3 Market size and forecast7.4 Reimbursement scenarioCHAPTER 8 SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)8.1 Key market trends8.2 Key growth factors and opportunities8.3 Market size and forecast8.4 Reimbursement scenarioCHAPTER 9 DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)9.1 Key market trends9.2 Key growth factors and opportunities9.3 Market size and forecast9.4 Reimbursement scenarioCHAPTER 10 FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)10.1 Key market trends10.2 Key growth factors and opportunities10.3 Market size and forecast10.4 Reimbursement scenarioCHAPTER 11 OTHER EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)11.1 Key market trends11.2 Key growth factors and opportunities11.3 Market Size and Forecast11.4 Reimbursement Scenario11.4.1 Israel11.4.2 The Netherlands11.4.3 Slovenia11.4.4 Spain11.4.5 SwitzerlandCHAPTER 12 COMPANY PROFILES12.1 Medtronic Inc.12.1.1 Company overview12.1.2 Company snapshot12.1.3 Business performance12.1.4 Strategic moves and developments12.1.4.1 Principal strategies: product launch12.1.4.2 Secondary strategies: approval12.1.4.3 Other strategies: strategic alliance and collaboration12.1.5 SWOT analysis of Medtronic Inc.12.2 Dexcom Inc.12.2.1 Company overview12.2.2 Company snapshot12.2.3 Business performance12.2.4 Strategic moves and developments12.2.4.1 Principal strategies: agreement/partnership12.2.4.2 Secondary strategies: approval12.2.4.3 Other strategies: acquisition12.2.5 SWOT analysis of Dexcom12.3 Abbott Diabetic Care (Abbott Laboratories)12.3.1 Company overview12.3.2 Company snapshot12.3.3 Business performance12.3.4 Strategic moves and developments12.3.5 SWOT analysis of Abbott diabetic care12.4 Senseonics, Incorporated12.4.1 Company overview12.4.2 Company snapshot12.4.3 Strategic moves and development12.4.4 SWOT analysis of Senseonics12.5 Animas Corporation12.5.1 Company overview12.5.2 Company snapshot12.5.3 Strategic moves and developments12.5.4 SWOT analysis of Animas Corporation12.6 Insulet Corporation12.6.1 Company overview12.6.2 Company snapshot12.6.3 Strategic moves and developments12.6.4 SWOT analysis of INSULET Corporation12.7 Echo Therapeutics12.7.1 Company Overview12.7.2 Company snapshot12.7.3 Strategic moves and development12.7.4 SWOT analysis of Echo Therapeutics12.8 Glysens Inc.12.8.1 Company overview12.8.2 Company snapshot12.8.3 Strategic moves and developments12.8.4 SWOT analysis of Glysens Inc.List of TablesTABLE 1 EUROPE CGMS MARKET BY COUNTRY, 2014-2021, ($THOUSANDS)TABLE 2 U.K. CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)TABLE 3 GERMANY CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)TABLE 4 FRANCE CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)TABLE 5 NORWAY CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)TABLE 6 SWEDEN CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)TABLE 7 DENMARK CGMS MARKET BY COMPONENTS, 2014-2021 ($THOUSANDS)TABLE 8 FINLAND CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)TABLE 9 OTHER EUROPE CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)TABLE 10 MEDTRONIC BUSINESS SNAPSHOTTABLE 11 DEXCOM INC. BUSINESS SNAPSHOTTABLE 12 ABBOTT DIABETIC CAREBUSINESS SNAPSHOTTABLE 13 SENSEONICS SNAPSHOTTABLE 14 ANIMAS CORPORATION BUSINESS SNAPSHOTTABLE 15 INSULET CORPORATION BUSINESS SNAPSHOTTABLE 16 GLYSENS INC. BUSINESS SNAPSHOTList of FiguresFIG. 1 MEDTRONIC REVENUE BY BUSINESS UNITS (2014)FIG. 2 MEDTRONIC REVENUE BY GEOGRAPHY (2014)FIG. 3 SWOT ANALYSIS OF MEDTRONICFIG. 4 SWOT ANALYSIS OF DEXCOM INC.FIG. 5 REVENUE BY BUSINESS SEGMENT (2014)FIG. 6 SWOT ANALYSIS OF ABBOTT DIABETIC CAREFIG. 7 SWOT ANALYSIS OF SENSEONICSFIG. 8 SWOT ANALYSIS OF ANIMAS CORPORATIONFIG. 9 SWOT ANALYSIS OF INSULET CORPORATIONFIG. 10 SWOT ANALYSIS OF ECHO THERAPEUTICSFIG. 11 SWOT ANALASIS OF GLYSEN INCORPORATED

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Continuous Glucose Monitoring 2016 - MedCore

European Market Report for Continuous Glucose Monitoring 2016 - MedCore

  • $ 5495
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European CGM market comprises the CGM system segment and the CGM sensor segment. The business model for CGM is similar to traditional blood glucose meters, where the CGM system is the base equipment ...

US Market Report for Blood Glucose Test Strips 2017 - MedCore

US Market Report for Blood Glucose Test Strips 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market ...

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.